Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
182
datasets available to search
ShareScore release 0.9.0
Dataset results
182 results for “MSS”
Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer
ClinicalTrials.gov study NCT05914389. IPD Sharing: NO. Countries: 1. Publications: 0.
Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC
ClinicalTrials.gov study NCT04653480. IPD Sharing: NO. Countries: 1. Publications: 0.
KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05985109. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroeso
ClinicalTrials.gov study NCT05216237. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal Cancer
ClinicalTrials.gov study NCT06566755. IPD Sharing: YES. Countries: 1. Publications: 0.
Total Neoadjuvant Therapy With Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Ultra Low Rectal Adenocarcinoma
ClinicalTrials.gov study NCT05858567. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer
ClinicalTrials.gov study NCT06507371. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)
ClinicalTrials.gov study NCT06959693. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer
ClinicalTrials.gov study NCT05839470. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06011330. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Chemoradiotherapy Plus Sintilimab for MSS, Locally Advanced Rectal Cancer-
ClinicalTrials.gov study NCT06895577. IPD Sharing: NO. Countries: 1. Publications: 0.
The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer
ClinicalTrials.gov study NCT06254521. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer
ClinicalTrials.gov study NCT07154316. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectabl
ClinicalTrials.gov study NCT06282445. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer
ClinicalTrials.gov study NCT07025850. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM
ClinicalTrials.gov study NCT06045286. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Treatment in BRAF V600E Mutated MSS Initially Resectable or Potentially Resectable
ClinicalTrials.gov study NCT06207656. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05959356. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
ClinicalTrials.gov study NCT06551207. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
ClinicalTrials.gov study NCT04963283. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.